Discover the complete record of transactions filed by Cunningham David, 董事. Director active across 1 company, notably Immucell CORP. In total, 1 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €8k. Activity tracked since 13 June 2022. The latest transaction was filed on 13 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
David Cunningham is a Board Member at ImmunoCell Corp. He contributes to the strategic direction of the company, which focuses on immunological solutions. His expertise in the sector is crucial in guiding strategic decisions and supporting innovation.